VOGLIDIN GM2

VOGLIDIN GM2 contains Glimepiride 2 mg + Metformin (SR) 500 mg + Voglibose 0.2 mg, a triple-combination therapy for effective type 2 diabetes management. Glimepiride helps stimulate insulin release, Metformin improves insulin sensitivity and reduces glucose production, while Voglibose delays carbohydrate absorption to control post-meal sugar spikes. This combination supports stable blood sugar levels and better long-term glycemic control.